Bernat Olle, PhD

CEO
Vedanta Biosciences
Cambridge, MA, United States

Disclosure(s): Vedanta Biosciences, Inc.: Board Member, Ownership Interest, Stocks/Bonds (Private Company)

Presentation(s):

• 377 - Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)

  Friday, October 18, 2024
  1:57 PM – 2:09 PM US PT